Amgen sues Cipla for patent infringement

30-09-2016

Amgen sues Cipla for patent infringement

Makistock / shutterstock.com

Amgen has filed a complaint against Cipla for allegedly infringing a patent centring on Sensipar (cinacalcet hydrochloride), which treats an overactive thyroid.


Amgen, Cipla, patent, Sensipar, FDA, ANDA

LSIPR